Investigating the Effects of Moxibustion on Gastrointestinal Function and Gut Microbiota in Chronic renal failure: A CARE Non-Placebo Randomized Controlled Study in Peritoneal Dialysis Patients.
Weiguo Yao, Chunli Yu, Aiying Xiong, Li Li, Junli Gao, Kun Liu
{"title":"Investigating the Effects of Moxibustion on Gastrointestinal Function and Gut Microbiota in Chronic renal failure: A CARE Non-Placebo Randomized Controlled Study in Peritoneal Dialysis Patients.","authors":"Weiguo Yao, Chunli Yu, Aiying Xiong, Li Li, Junli Gao, Kun Liu","doi":"10.1159/000545242","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Moxibustion is regarded as a complementary and alternative treatment for chronic renal failure (CRF) patients.</p><p><strong>Methods: </strong>This study was a randomized controlled trial, we collected case data from 52 CRF patients who received moxibustion combined with PD treatment (moxibustion group) and 50 CRF patients who only received PD treatment (control group) in our hospital from March 2020 to February 2022. After a 12-week treatment cycle, the changes in blood routine test indicators, blood electrolytes, routine biochemical indicators, 24h urinary protein quantification, and gastrointestinal function indicators before and after treatment were compared between the two groups. The primary outcome was blood urea nitrogen (BUN) levels, indicative of kidney function.</p><p><strong>Results: </strong>52 patients remained in the Moxibustion group and 50 in the control group. After 12 weeks of treatment, the moxibustion group demonstrated significantly lower serum potassium and phosphorus levels than before treatment. Regarding biochemical blood analysis, the moxibustion group had significantly lower blood urea nitrogen levels, 24 h urinary protein quantification, and parathyroid hormone after treatment compared with the control group. However, although the serum creatinine, alkaline phosphatase, alanine aminotransferase and aspartate aminotransferase were numerically lower in the moxibustion group, the difference between the two groups was not statistically significant. The moxibustion group had improved gastrointestinal function, in terms of increased motilin and cholecystokinin levels, compared to the control group.</p><p><strong>Conclusion: </strong>Moxibustion combined with PD can improve renal and gastrointestinal functions and regulate the structure of the gut microbiota to in CRF patients.</p>","PeriodicalId":8953,"journal":{"name":"Blood Purification","volume":" ","pages":"1-23"},"PeriodicalIF":2.2000,"publicationDate":"2025-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Blood Purification","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000545242","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Moxibustion is regarded as a complementary and alternative treatment for chronic renal failure (CRF) patients.
Methods: This study was a randomized controlled trial, we collected case data from 52 CRF patients who received moxibustion combined with PD treatment (moxibustion group) and 50 CRF patients who only received PD treatment (control group) in our hospital from March 2020 to February 2022. After a 12-week treatment cycle, the changes in blood routine test indicators, blood electrolytes, routine biochemical indicators, 24h urinary protein quantification, and gastrointestinal function indicators before and after treatment were compared between the two groups. The primary outcome was blood urea nitrogen (BUN) levels, indicative of kidney function.
Results: 52 patients remained in the Moxibustion group and 50 in the control group. After 12 weeks of treatment, the moxibustion group demonstrated significantly lower serum potassium and phosphorus levels than before treatment. Regarding biochemical blood analysis, the moxibustion group had significantly lower blood urea nitrogen levels, 24 h urinary protein quantification, and parathyroid hormone after treatment compared with the control group. However, although the serum creatinine, alkaline phosphatase, alanine aminotransferase and aspartate aminotransferase were numerically lower in the moxibustion group, the difference between the two groups was not statistically significant. The moxibustion group had improved gastrointestinal function, in terms of increased motilin and cholecystokinin levels, compared to the control group.
Conclusion: Moxibustion combined with PD can improve renal and gastrointestinal functions and regulate the structure of the gut microbiota to in CRF patients.
期刊介绍：
Practical information on hemodialysis, hemofiltration, peritoneal dialysis and apheresis is featured in this journal. Recognizing the critical importance of equipment and procedures, particular emphasis has been placed on reports, drawn from a wide range of fields, describing technical advances and improvements in methodology. Papers reflect the search for cost-effective solutions which increase not only patient survival but also patient comfort and disease improvement through prevention or correction of undesirable effects. Advances in vascular access and blood anticoagulation, problems associated with exposure of blood to foreign surfaces and acute-care nephrology, including continuous therapies, also receive attention. Nephrologists, internists, intensivists and hospital staff involved in dialysis, apheresis and immunoadsorption for acute and chronic solid organ failure will find this journal useful and informative. ''Blood Purification'' also serves as a platform for multidisciplinary experiences involving nephrologists, cardiologists and critical care physicians in order to expand the level of interaction between different disciplines and specialities.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
